Article Versions Notes

Miyagawa T, Chen Z-Y, Chang C-Y, Chen K-H, Wang Y-K, Liu G-S, Tseng C-L. Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization via Inhibition of VEGF Production. Pharmaceutics. 2020; 12(5):404. https://doi.org/10.3390/pharmaceutics12050404

Miyagawa, Takuya, Zhi-Yu Chen, Che-Yi Chang, Ko-Hua Chen, Yang-Kao Wang, Guei-Sheung Liu, and Ching-Li Tseng. 2020. "Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization via Inhibition of VEGF Production" Pharmaceutics 12, no. 5: 404. https://doi.org/10.3390/pharmaceutics12050404

Miyagawa, T., Chen, Z.-Y., Chang, C.-Y., Chen, K.-H., Wang, Y.-K., Liu, G.-S., & Tseng, C.-L. (2020). Topical Application of Hyaluronic Acid-RGD Peptide-Coated Gelatin/Epigallocatechin-3 Gallate (EGCG) Nanoparticles Inhibits Corneal Neovascularization via Inhibition of VEGF Production. Pharmaceutics, 12(5), 404. https://doi.org/10.3390/pharmaceutics12050404